Table 1.
Baseline characteristics of control and intervention groups.
| Variable | Control | Intervention | P value |
|---|---|---|---|
| Age | 63.08 ± 13.9 | 58.86 ± 16.68 | 0.357 |
| BMI (kg/m2) | 23.79 ± 4.17 | 25.59 ± 4.25 | 0.153 |
| hs-CRP | 10508.52 ± 5479.98 | 8953.30 ± 5588.06 | 0.346 |
| PCO | 22.19 ± 4.26 | 20.33 ± 4.40 | 0.153 |
| NO metabolite | 9.12 ± 5.88 | 12.25 ± 7.66 | 0.142 |
| TNF-α (pg/mL) | 15.95 (15.17, 16.66) | 15.96 (15.16, 16.66) | 0.785 |
| IL-6 (pg/mL) | 58.24 (55.19, 61.12) | 60.10 (55.99, 73.10) | 0.075 |
| Vit E | 740.00 ± 104.12 | 703.05 ± 73.91 | 0.186 |
Values are mean ± SD for the data with normal distribution and median (interquartile ranges) for the data not normally distributed. BMI: body mass index; CRP: C-reactive protein; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; PCO: protein carbonyl; NO metabolite: nitric oxide metabolite; Vit E: vitamin E.